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Age-dependent cerebrovascular abnormalities and blood flow
disturbances in APP23 mice modeling Alzheimer's disease
Abstract
Neuropathological changes associated with Alzheimer's disease (AD) such as amyloidplaques, cerebral
amyloid angiopathy, and related pathologies are reproduced in APP23 transgenic mice overexpressing
amyloid precursor protein (APP) with the Swedish mutation. Magnetic resonance angiography (MRA)
was applied to probe, in vivo, the cerebral arterial hemodynamics of these mice. Flow voids were
detected at the internal carotid artery of 11-month-old APP23 mice. At the age of 20 months, additional
flow disturbances were observed in large arteries at the circle of Willis. Vascular corrosion casts
obtained from the same mice revealed that vessel elimination, deformation, or both had taken place at
the sites where flow voids were detected by MRA. The detailed three-dimensional architecture of the
vasculature visible in the casts assisted the identification of smaller vessels most likely formed as
substitution or anastomosis within the circle of Willis. Angiograms and corrosion casts from
nontransgenic, age-matched mice manifested no major abnormalities in the cerebrovascular arterial flow
pattern. Because no transgene overexpression has been found in the cerebrovasculature of APP23 mice
and no deposits of amyloid-beta (Abeta) were observed in large arteries in the region of the circle of
Willis, the present results suggest that soluble Abeta may exert deleterious effects on the vasculature.
Our findings support the idea that cerebral circulatory abnormalities evolving progressively could
contribute to AD pathogenesis. The study also shows the power of MRA to identify changes of vascular
function in genetically engineered mice. MRA as a noninvasive technique could be applied to test new
therapeutic concepts in animal models of AD and in humans.
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Neuropathological changes associated with Alzheimer’s disease (AD) such as amyloid plaques, cerebral amyloid angiopathy, and related pathol-
ogies are reproduced in APP23 transgenic mice overexpressing amyloid precursor protein (APP) with the Swedish mutation. Magnetic reso-
nance angiography (MRA) was applied to probe, in vivo, the cerebral arterial hemodynamics of these mice. Flow voids were detected at the
internal carotid artery of 11-month-old APP23 mice. At the age of 20 months, additional flow disturbances were observed in large arteries at the
circle of Willis. Vascular corrosion casts obtained from the same mice revealed that vessel elimination, deformation, or both had taken place at
the sites where flow voids were detected by MRA. The detailed three-dimensional architecture of the vasculature visible in the casts assisted the
identification of smaller vessels most likely formed as substitution or anastomosis within the circle of Willis. Angiograms and corrosion casts
from nontransgenic, age-matched mice manifested no major abnormalities in the cerebrovascular arterial flow pattern. Because no transgene
overexpression has been found in the cerebrovasculature of APP23 mice and no deposits of amyloid- (A) were observed in large arteries in the
region of the circle of Willis, the present results suggest that soluble Amay exert deleterious effects on the vasculature. Our findings support the
idea that cerebral circulatory abnormalities evolving progressively could contribute to AD pathogenesis. The study also shows the power of MRA
to identify changes of vascular function in genetically engineered mice. MRA as a noninvasive technique could be applied to test new therapeutic
concepts in animal models of AD and in humans.
Key words: Alzheimer’s disease; amyloid precursor protein (APP); angiography; angiopathy; cerebral amyloid angiopathy (CAA); circle of
Willis; magnetic resonance angiography (MRA); magnetic resonance imaging (MRI); soluble amyloid; transgenic mice; vascular corro-
sion cast
Introduction
The pathology of Alzheimer’s disease (AD) is characterized by
amyloid- (A) peptide-containing plaques, neurofibrillary tan-
gles consisting of aggregated, hyperphosphorylated tau, extensive
neuritic degeneration, and distinct neuron loss. The typical clin-
ical picture of AD includes a progressive decline of memory func-
tion, often accompanied by other clinical signs such as agitation,
aggression, sleep disturbances, and social withdrawal. Vascular
abnormalities coexist commonly with the histological features of
AD (Snowdon et al., 1997; Sparks, 1997; Grammas, 2000). Dep-
osition of A peptide in cerebral vessel walls, known as cerebral
amyloid angiopathy (CAA), is very frequent, but its contribution
to the onset of dementia is unknown (De la Torre and Mussivand,
1993). In fact, hemorrhages correlating with CAA and AD often
occur in vessels not affected by amyloid deposition (Gilbert and
Vinters, 1983).
Transgenic mice play a fundamental role in the study of AD
mechanisms (for review, see Bornemann and Staufenbiel, 2000;
Andersen, 2001; Duff and Rao, 2001; Hock and Lamb, 2001) and
are used to test novel therapies. APP23 mice contain a human
amyloid precursor protein (APP751) cDNA with the Swedish
double mutation at position 670/671 under the control of the
neuron-specific Thy-1 promoter. These animals express APP in
sevenfold excess compared with the endogenous murine APP.
Although the transgenic APP expression is turned on during the
first month after birth, A deposition starts at6 months of age
in female mice (and 1–2 months later in male mice) in the frontal
cortex and in the subiculum. The deposits increase in number
and size thereafter and finally occupy substantial portions of the
neocortex, hippocampus, and thalamus (Sturchler-Pierrat et al.,
1997). Although the APP transgene is only expressed in neurons,
in addition to amyloid plaques, the mouse model develops sub-
stantial cerebrovascular accumulation of A easily detectable at
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the age of 12 months (Calhoun et al., 1999; Bornemann and
Staufenbiel, 2000; Sturchler-Pierrat and Staufenbiel, 2000). CAA
and associated pathologies such as alterations in the vascular in-
tegrity and microhemorrhages (Winkler et al., 2001) exhibit sim-
ilarities to what is observed in aged individuals and AD patients
(Probst et al., 1991; Staufenbiel and Sommer, 1998).
Recently, high-resolution magnetic resonance angiography
(MRA) has been introduced as a means to investigate the arterial
cerebrovascular hemodynamics noninvasively in rats (Reese et
al., 1999) and mice (Beckmann et al., 1999; Beckmann, 2000). In
the work reported here, the technique was used to probe the
cerebral arterial hemodynamics of APP23 transgenic mice in vivo.
Angiograms were compared with vascular corrosion casts
(Meyer, 1989; Meyer et al., 2000) to identify the underlying struc-
tural changes.
Materials and Methods
Experiments were performed according to Swiss federal regulations for
animal protection and were approved by the Veterinary Authority of
Basel.
Animals. Ten-month-old male C57Bl/6 mice (Iffa Credo, St. Aulbin-
les-Elbeuf, France) served as an independent control group (n 8).
The generation of APP23 mice containing the murine Thy-1 promoter
driving neuron-specific expression of human mutated APP751 was de-
scribed in detail by Sturchler-Pierrat et al. (1997). MRA and cast studies
were performed on male APP23 mice and controls from the same or
parallel litters at ages of 6.8 1 (6.5 1 for controls), 11.3 1 (11.4
1 for controls), and 20.1 1 (20.2 1 for controls) months. Ten animals
were examined in each group at the different ages. Male APP23 mice at 7
months of age contain only a few isolated amyloid plaques. The plaque
load (expressed as a percentage of neocortical area) is in the range of 0.3%
at 12 months to 9% at 22 months of age.
Histological analysis was performed on another cohort of 12-, 14-, and
22-month-old APP23 mice, with 10 animals in each age group.
MRA. For the MRA investigations, animals were anesthetized with
1.3% isoflurane (Abbott, Cham, Switzerland) in a mixture of oxygen and
N2O (1:2) administered via a face mask. The body temperature of the
mice was kept at 37°C. No stereotactic holding was used.
Measurements were performed with a Biospec 47/40 spectrometer
(Bruker, Karlsruhe, Germany) operating at 4.7 T, equipped with an ac-
tively shielded gradient system. The operational software of the scanner
was Paravision (Bruker). Time-of-flight (TOF) angiograms were ob-
tained using a three-dimensional (3D) gradient-echo sequence with the
following imaging parameters: repetition time, 40 msec; echo time, 1.6
msec; matrix, 96 192 64; field-of-view, 1.44 1.92 0.64 cm 3; and
two averages. Total acquisition time for an angiogram was 16.4 min. The
radio frequency pulse was frequency-selective, thereby exciting a coronal
slice 0.64 cm thick. The excitation pulse was20°. Magnetization trans-
fer contrast was attained by a frequency-selective Gaussian pulse of 3500
sec duration, with 2T strength and a frequency offset of 2500 Hz with
respect to the water resonance, preceding the 3D gradient-echo sequence
by 2.4 msec. An Alderman–Grant-type resonator of 2 cm diameter was
used for excitation and detection. The pixel size of the raw data was 150
100  100 m 3. All data were zero-filled to (256) 3 for reconstruction.
Angiograms were obtained by generating maximum-intensity projec-
tions (MIPs) using standard software from the magnetic resonance (MR)
system after zero-filling the raw data. The MRA acquisition parameters
had been optimized previously (Beckmann et al., 1999; Beckmann, 2000)
in normal wild-type mice of different strains matching in weight to the
animals participating in this study.
Vascular corrosion cast. Mice were deeply anesthetized with pentobar-
bital (100 mg/kg, i.p.) and perfused through the left ventricle of the heart.
The left ventricle was punctured with a 19 gauge needle from a winged
infusion set (SV-19BLK; Termudo, Elkton, MD), which was connected
to an airtight pressurized syringe containing the rinsing solution (Ring-
er’s solution with 250,000 U/l heparin at 35°C). The right atrium was
punctured to provide outflow, and the perfusate was injected under a
pressure of80 –100 mmHg. The perfusion was continued for 2–5 min
at a constant rate (20 –30 ml) followed by a prefixation solution (35°C, 20
ml, 4% performaldehyde in PBS). Immediately afterward, 10 ml of resin
(Mercox/methyl-methacrylate; Ladd Research, Burlington, VT) was in-
fused at the same rate. The resin-filled tissue was kept at room tempera-
ture overnight to complete resin curing. Soft tissue was removed from the
head by maceration in 20% KOH during 24 hr at 50°C, followed by
decalcification in 5% formic acid (12 hr). The casts were then thoroughly
cleaned with and stored in distilled water before drying by lyophilization.
Mounted on stubs, the casts were sputter-coated with gold-palladium for
routine scanning electron microscopy. To quantify microvascular
changes, photomicrographs were scanned, and the imaging software
Image-Pro Plus (Media Cybernetics, Inc., Des Moines, IA) was used to
measure diameters of capillaries between ramifications. Photo Paint
(Corel Corp., Ottawa, Ontario, Canada) was used for photo montage.
Histology and immunohistochemistry. Histological analyses were per-
formed according to procedures described by Sturchler-Pierrat et al.
(1997) on brains from 12-, 14-, and 22-month-old APP23 mice. Brains
from 10 animals in each age group were examined at different anatomical
levels.
Results
The arterial cerebrovascular structure of living mice can be de-
picted by TOF MRA, which is sensitive to fast-flowing blood.
Figure 1 shows a representative coronal MIP image from an an-
giogram of the head of a C57Bl/6 mouse. The circle of Willis as
well as the middle and posterior cerebral arteries are well delin-
eated, whereas venous structures are almost completely sup-
pressed because of the low flow velocity.
A representative angiogram from 6-month-old APP23 trans-
genic mice is presented in Figure 2a. No major flow abnormalities
were detected in the arterial cerebrovascular architecture at this
age. Only minor flow voids were detected at the level of the ptery-
gopalatine arteries outside the brain (in 5 of 10 mice; Table 1).
Except for this change, angiograms from 6-month-old APP23
mice (Fig. 2a) were very similar to those obtained for control
C57Bl/6 mice (Fig. 1). Angiograms from age-matched wild-type
littermates were devoid of flow disturbances (data not shown).
Corrosion casts from the brains of mice10 months also showed
no major abnormalities in the large cerebral arteries. A represen-
tative cast from a young APP23 mouse is displayed in Figure 2b.
At the age of 11 months, flow disturbances were present at the
level of the carotid arteries in 7 of 10 APP23 mice (Fig. 3, Table 1).
Figure 1. Angiogram from a normal 10-month-old C57Bl/6 mouse. The circle of Willis (1, 2,
4) and small vessels emerging from it are well delineated.
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Flow voids were also detected in arteries outside the brain, at the
level of the pterygopalatine, and in the external and common
carotid arteries. No significant flow disturbances were seen in
age-matched control littermates.
The angiogram of a 20-month-old littermate mouse (Fig. 4a)
was comparable with that of a C57Bl/6 control mouse (Fig. 1)
except for flow voids appearing at the level of the pterygopalatine
and the internal carotid artery (comparable in extent with APP23
transgenic mice of age 11 months; Fig. 2b). The intact flow pat-
tern in the circle of Willis was confirmed by cast analysis of the
cerebrovascular architecture of the same animal (Fig. 4b). Angio-
grams from six other 20-month-old littermate mice showed mi-
nor flow voids at the level of the pterygopalatine only, whereas the
remaining three animals in this group had intact angiograms
(Table 1).
In contrast, angiograms from 6 of 10 APP23 mice at 20
months of age presented significant flow voids in the main arter-
ies of the circle of Willis. In addition to flow disturbances at the
level of the pterygopalatine and the carotid arteries, large flow
voids were seen in the anterior and posterior cerebral arteries and
the middle cerebral arteries (Fig. 5a). Corrosion cast technology
helped interpret the flow disturbances occurring in the angio-
grams. Vessel elimination and substitution (or rearrangement)
occurred at the level of the posterior cerebral arteries (Fig. 5b),
where a significant flow void had been detected by MRA (Fig. 5a).
Instead of a well developed posterior cerebral artery, multiple
small vessels were present at this level on the left side of the circle
of Willis (Fig. 5b, inset, compare with the right side and Fig. 1).
Closer analysis of the angiogram reveals remaining flow through
these tiny vessels (Fig. 5a). Also, the absent internal carotid artery
on the left side of the angiogram was detected as vessel elimina-
tion by cast analysis. Interesting was the presence of a small artery
connecting the left and right sides of the circle of Willis (Fig. 5a,b,
#). This vessel, which appeared faintly in the angiogram and
could have been easily overlooked, probably maintained a dimin-
utive flow around the circle of Willis in face of the vessel substi-
tution at the level of the posterior cerebral arteries. Turbulence
resulting from constriction of vessels could have been another
cause of flow perturbation. Narrowing was present in the right
middle cerebral artery (Fig. 5c), internal carotid artery (Fig. 5d),
and posterior cerebral artery (Fig. 5e, left). Also, an inclusion of
yet undetermined origin was detected at the level of the posterior
cerebral artery (Fig. 5e, right). A summary of observed changes is
shown in Table 1.
As already indicated in Figure 5, an asymmetric flow pattern at
the level of the circle of Willis and also outside the brain was
systematically observed in 20-month-old APP23 mice. Figure 6a
exemplifies this for the middle cerebral artery and, in addition,
for the pterygopalatine, where a large flow void on the right side
Figure 3. Angiogram from an 11-month-old APP23 mouse. The arrows indicate flow distur-
bances at the level of the internal carotid arteries (5). Flow disturbances were also detected
outside the brain, at the common (7) and external (8) carotid arteries and the pterygopalatine
(10, 11).
Table 1. Summary of the vascular alterations observed in APP23 and littermate mice using MRA and corrosion casts
Artery Location MRA Cast
APP23 Wild-type
6 –7 months 11 months 20 months 7 months 11 months 20 months
1. Anterior cerebral Brain Flow voids Narrowing, elimination 6/10
2. Superior cerebellar Brain
3. Middle cerebral Brain Flow voids Narrowing 6/10
4. Posterior cerebral Brain Flow voids Narrowing, elimination 6/10
5. Internal carotid Brain Flow voids, elimination Narrowing, elimination 7/10 8/10 1/10
6. Basilar Brain
7. Common carotid Periphery Flow voids Not analyzed 7/10 8/10
8. External carotid Periphery Flow voids Not analyzed 7/10 8/10
9. Vertebral Periphery Not analyzed
10. Palatine Periphery Flow voids Not analyzed 5/10 8/10 10/10 7/10
11. Pterygopalatine Periphery Flow voids Not analyzed 5/10 8/10 10/10 7/10
Ten animals were analyzed at each age. The numbers express how many animals showed alterations at a given artery.
Figure 2. a, Angiogram from a 6-month-old APP23 mouse. No flow disturbances were de-
tected by MRA in the cerebrovascular architecture of transgenic mice at this age. Minor flow
voids were seen only at the level of the pterygopalatine arteries (11). b, Corrosion cast from the
brain of a 7.5-month-old APP23 mouse. An intact circle of Willis is shown.
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seemed to be compensated by an abnor-
mally elevated flow on the corresponding
contralateral artery. Cast analysis showed
differences in diameters of the middle ce-
rebral arteries of this animal (Fig. 6b).
Histology performed on an additional
cohort of 22-month-old APP23 mice re-
vealed deposition of amyloid in large lep-
tomeningeal and neocortical arteries.
However, no significant amyloid deposi-
tion was found in veins and in large arter-
ies in the region of the circle of Willis.
Discussion
In this study we show evidence of age-
dependent alterations of cerebral blood
flow and vascular architecture in APP23
transgenic mice using MRA and corrosion
casts.
Age-related blood flow disturbances
attributable to cerebrovascular
abnormalities in APP23 mice
Angiograms from 6-month-old APP23 mice showed normal, un-
disturbed arterial cerebrovascular blood flow, similar to that of
young nontransgenic animals (Beckmann et al., 1999; Beck-
mann, 2000). Localized flow voids at the level of the internal
carotid arteries were apparent in APP23 mice at the age of 11
months. In 20-month-old mice, in addition to the carotids, sub-
stantial flow perturbations also affected other main arteries from
the circle of Willis, the middle cerebral and the posterior cerebral
arteries. Analysis of corrosion casts demonstrated that vessel
elimination and substitution occurred at regions of the arterial
cerebrovascular architecture where substantial flow voids had
been detected by MRA. They also confirmed a loss of vessels in
the circle of Willis. In contrast, angiograms and corrosion casts
from nontransgenic mice manifested no major abnormalities in
the cerebrovascular arterial flow pattern at any age.
A number of inseparably and dynamically interrelated factors,
such as flow velocity, microturbulent flow, viscosity of blood,
shear stress caused by the vascular wall, and vascular resistance,
govern the dynamics of blood flow in cerebral vessels (De la Torre
and Mussivand, 1993). Microturbulent flow, which disturbs the
regular passage of blood, can develop when the usual shape of the
vascular lumen becomes irregular, for example, locally thickened
(as for fibrotic arteries), partially obstructed (atherosclerosis), or
compressed. In this case, the flow pattern may become disrupted,
and random swirls can build up, compromising the slow flow of
the cell-free layer near the vessel wall. Thus, localized flow voids
in the angiograms do not necessarily mean absence of flow but
may be the consequence of microturbulence.
To help interpret the MRA data and to identify structural
alterations underlying the dynamic MRA observations, we per-
formed corrosion cast analysis. This method is unique because
the three-dimensional organization of the vasculature is retained,
including the dense network of the capillaries. Not only did casts
confirm the MRA data, in addition, this method also helped de-
vise possible explanations for the flow irregularities in the form of
focal constriction of arteries, vessel elimination and rearrange-
ment (see below), or the presence of inclusions. Although casting
procedures have technical limitations, in the present situation,
this technique is superior to standard histology because the three-
dimensional organization is retained.
Vessel rearrangement
In old APP23 mice, analysis of casts showed that vessel rearrange-
ment and substitution occurred in the circle of Willis at locations
where elimination of parts of arteries had taken place (Fig. 5),
indicating that angiogenesis had occurred at these sites. These
observations are consistent with intrathecal production of trans-
forming growth factor , a cytokine exerting both anti-
inflammatory and angiogenic properties, as well as promoting
amyloidogenesis, observed in AD patients (Tarkowski et al.,
2002) and in APP23 mice older than 12 months (S. Wiesli and M.
Staufenbiel, unpublished results).
Cerebrovascular abnormalities in transgenic models of AD
and in patients
Significant amounts of neuron-derived cerebrovascular amyloid
have been reported in APP23 mice (Calhoun et al., 1999; Burger-
meister et al., 2000; Winkler et al., 2001), leading to vascular
damage. The frequency and severity of CAA in these animals are
age-related. In 8-month-old APP23 mice, cerebrovascular amy-
loid is generally absent except for rare focal deposits in leptomen-
ingeal vessels. In animals of 19 months, cerebrovascular amy-
loid deposits are encountered consistently throughout the
neocortex, hippocampus, and thalamus. Leptomeningeal vessels
are always heavily affected at this age (Winkler et al., 2001), a fact
that was confirmed here by histological analysis.
Whereas deposition of amyloid in large arteries was seen only
in leptomeningeal and neocortical arteries, MRA detected flow
voids at the middle cerebral artery and at the level of the circle of
Willis in old APP23 mice. These results indicate that vascular
changes can be observed even when the amount of amyloid dep-
osition on the vessels is negligible. Although fibril formation of
A, leading to neurodegeneration and death, has constituted an
important paradigm in AD research (Hardy and Higgins, 1992),
soluble A peptides display free radical-mediated vasoactive
properties (Thomas et al., 1996) and have been shown recently to
elicit vasoconstriction of vessels as large as the human middle
cerebral and basilar arteries (Townsend et al., 2002). Circulating
A (1– 40) can exert vasopressor actions in vivo (Arendash et al.,
1999; Niwa et al., 2001), suggesting a pathophysiologic role for
soluble A in AD that precedes A deposition and dementia
onset. Moreover, Price et al. (1997) showed that the A peptide
produces dysfunction in cerebral vessels, including large arteries
Figure 4. Twenty-month-old littermate mouse. a, Coronal MIP image of an angiogram from a 20-month-old wild-type mouse.
The arrows indicate flow voids at the level of the left internal carotid artery (5) and the pterygopalatine (10, 11). b, Corresponding
corrosion cast showing no abnormalities in the circle of Willis of this animal.
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(e.g., posterior communicating arteries), which can lead to endo-
thelial cell death. There is mounting evidence suggesting that
soluble, oligomeric A assemblies cause substantial neuronal
dysfunction before the appearance of amyloid deposits (Klein et
al., 2001; Walsh et al., 2002). Amyloid fibril formation and dep-
osition thus may be later stages of a process in which pathogenic
events already occur early and are mediated by oligomeric assem-
blies (Kirkitadze et al., 2002; Selkoe, 2002). In APP23 transgenic
mice, CAA is not formed by A from vascular cells or the blood
but originates from transport and drainage of neuronally pro-
duced A (Calhoun et al., 1999; Burgermeister et al., 2000). Ac-
cordingly, it seems possible that soluble A oligomers were
drained along the large vessels of the circle of Willis, thereby
causing the flow disturbances seen with MRA. Our observations
are in line with reports from other transgenic mouse models of
AD that significant neuronal injury may occur before the appear-
ance of plaques (Hsia et al., 1999; Moechars et al., 1999; Kumar-
Singh et al., 2000; Mucke et al., 2000).
The arterial cerebrovascular abnormalities detected by MRA
and corrosion casts in the APP23 model are consistent with stud-
Figure 5. Twenty-month-old APP23 mouse. a, The arrows in the angiogram indicate flow voids at the level of the middle cerebral artery (3), the posterior cerebral arteries (4), the carotid arteries
(5, 7, 8), and the pterygopalatine (10, 11). b, Corresponding corrosion cast demonstrating vessel elimination at the level of the posterior cerebral artery (4) and the carotid arteries (5, 7, 8) on the left
side of the circle of Willis. c, d, Details of the cast presented in b showing constrictions at the level of the right middle cerebral (3) and the internal carotid (5) arteries, respectively. e, A constriction
(left, opposed arrows) and an inclusion of unknown kind (right, arrow) were detected at the level of the right posterior cerebral artery (4). The picture on the right was taken from the internal side
of the circle of Willis. Vessel constrictions and inclusions could be the cause of turbulence resulting in flow voids depicted by the MR angiograms.
Figure 6. Twenty-month-old APP23 mouse. a, Angiogram showing perturbed flow at the level of the middle cerebral arteries (3), the carotid arteries (5, 7, 8), and the pterygopalatine (10, 11).
b, Corrosion cast demonstrating the different diameters of the middle cerebral arteries.
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ies performed on brains of AD patients at autopsy, revealing that
arterioles frequently present deformations, for example, focal
constrictions, kinking, twisting, and looping, as well as smooth
muscle cells with an irregular shape and arrangement (Hassler,
1967; Scheibel et al., 1986; Kimura et al., 1991; Perry et al., 1998).
Also, stenoses and decreased blood flow velocity were demon-
strated in vivo in the middle cerebral arteries of patients with AD
(Franceschi et al., 1995; Ishibashi et al., 1998). In these patients,
there was an asymmetry in blood flow velocity, which positively
correlated with the cognitive asymmetry often seen in the early
phase of AD.
Alternative methods to assess brain perfusion in vivo
Another means for addressing the issue of cerebrovascular ab-
normalities in APP23 mice could be performing magnetic reso-
nance imaging (MRI) perfusion measurements using, for exam-
ple, an intravascular contrast agent (Rosen et al., 1991; Rudin et
al., 1997) or spin-labeling techniques (Alsop et al., 2000). Such
measurements, however, are only sensitive to large flow changes
and would not necessarily detect more localized vascular distur-
bances, as was the case in this work. Laser Doppler flowmetry can
also be used to monitor in vivo cerebral blood flow in the mouse
brain (Niwa et al., 2002), yet this method is invasive because
craniotomy needs to be performed to place the Doppler probe
over a region of interest (e.g., the somatosensory cortex). Fur-
thermore, measurements are spatially limited to the sensitive re-
gion of the probes, which typically have tip diameters smaller
than 1 mm.
The MRA procedure adopted here is noninvasive, except for
the anesthesia, and angiograms were generated without the use of
contrast agents. Thus, repetitive measurements performed on the
same animal are limited only by anesthesia. Also, information on
the arterial cerebrovascular architecture of the whole circle of
Willis is obtained. Drawbacks of MRA of the mouse brain are that
detected signals are restrained to main arteries and that the infor-
mation on flow is only qualitative because the angiogram appear-
ance depends not only on flow velocity. Evidently, being a
method of limited sensitivity, MRA needs to be complemented by
more refined techniques (e.g., corrosion cast technology), to ob-
tain further information on the disturbed cerebrovascular archi-
tecture at the level of smaller arteries and capillaries. However,
because of turbulence-induced signal attenuation in TOF MRA,
changes in the vascular structure may be detected before the net
flow through the vessel is affected.
In summary, using MRA, age-dependent flow voids were de-
tected in vivo in larger arteries at the level of the circle of Willis in
old but not in young APP23 transgenic mice. Corrosion cast
technology revealed that, at the sites where flow voids were de-
tected in vivo, vessel elimination, deformation, or both had taken
place. In addition, casts assisted the identification of smaller ves-
sels, most likely newly formed as substitution or anastomosis
within the circle of Willis. Because no deposits of aggregated A
were observed in large arteries in the region of the circle of Willis,
the present results suggest that soluble A may exert deleterious
effects on the vasculature. The loss of vascular integrity described
here might provide the basis for the age-related impairment of
the cerebral blood volume response to pharmacological stimula-
tion shown recently in brain functional MRI studies in APP23
mice (Mueggler et al., 2002). The present results thus support the
idea that cerebral microcirculatory abnormalities evolving pro-
gressively could contribute to AD pathogenesis and the cognitive
impairment.
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